{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T10:19:59Z","timestamp":1788085199876,"version":"build-2803163510"},"reference-count":84,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,10,26]],"date-time":"2023-10-26T00:00:00Z","timestamp":1698278400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,10,26]],"date-time":"2023-10-26T00:00:00Z","timestamp":1698278400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"the Science and Technology Support Program of Sichuan Province","award":["2023NSFSC1617"],"award-info":[{"award-number":["2023NSFSC1617"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Insights Imaging"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Primary biliary cholangitis (PBC) is a rare chronic autoimmune-mediated cholestatic liver disease involving medium and small bile ducts that can lead to liver fibrosis and cirrhosis. To date, the pathogenesis of PBC remains elusive, and there is currently no curative medical treatment. Computed tomography (CT) and magnetic resonance (MR) imaging, as common technical tools that allow non-invasive monitoring of liver tissue in vivo, play crucial roles in the diagnosis, staging, and prognosis prediction in PBC by enabling assessment of abnormalities in liver morphology and parenchyma, irregular configuration of bile ducts, lymphadenopathy, portal hypertension, and complications of cirrhosis. Moreover, CT and MRI can be used to monitor the disease progression after treatment of PBC (e.g. the onset of cirrhotic decompensation or HCC) to guide the clinical decisions for liver transplantation. With the optimization of imaging technology, magnetic resonance elastography (MRE) offers additional information on liver stiffness, allows for the identification of early cirrhosis in PBC and provides a basis for predicting prognosis. Gadoxetic acid-enhanced MRI enables the assessment of liver function in patients with PBC. The purpose of this review is to detail and illustrate the definition, pathological basis, and clinical importance of CT and MRI features of PBC to help radiologists and clinicians enhance their understanding of PBC.<\/jats:p><jats:p><jats:bold>Critical Relevance Statement<\/jats:bold><\/jats:p><jats:p>Characteristic CT and MR imaging manifestations of primary biliary cholangitis may reflect the course of the disease and provide information associated with histological grading and altered cellular function.<\/jats:p><jats:p><jats:bold>Key points<\/jats:bold><\/jats:p><jats:p>\u2022 Imaging has become highly useful for differentiating PBC from other diseases.<\/jats:p><jats:p>\u2022 Key pathological alterations of PBC can be captured by CT and MRI.<\/jats:p><jats:p>\u2022 Characteristic manifestations provide information associated with histological grade and cellular function.<\/jats:p><jats:p>\u2022 Despite this, the CT or MRI features of PBC are not specific.<\/jats:p>\n                <jats:p><jats:bold>Graphical Abstract<\/jats:bold><\/jats:p>","DOI":"10.1186\/s13244-023-01517-3","type":"journal-article","created":{"date-parts":[[2023,10,26]],"date-time":"2023-10-26T00:02:16Z","timestamp":1698278536000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["CT and MR imaging of primary biliary cholangitis: a pictorial review"],"prefix":"10.1186","volume":"14","author":[{"given":"Yun","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianying","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zixing","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7269-2101","authenticated-orcid":false,"given":"Bin","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,10,26]]},"reference":[{"key":"1517_CR1","doi-asserted-by":"crossref","unstructured":"European Association for the Study of the Liver (2017) EASL clinical practice guidelines: the diagnosis and management of patients with primary biliary cholangitis. J Hepatol 67(1):145\u2013172","DOI":"10.1016\/j.jhep.2017.03.022"},{"key":"1517_CR2","doi-asserted-by":"crossref","first-page":"197","DOI":"10.15403\/jgld-181","volume":"28","author":"K Wijarnpreecha","year":"2019","unstructured":"Wijarnpreecha K, Werlang M, Panjawatanan P et al (2019) Association between smoking and risk of primary biliary cholangitis: a systematic review and meta-analysis. J Gastrointestin Liver Dis 28:197\u2013203","journal-title":"J Gastrointestin Liver Dis"},{"key":"1517_CR3","doi-asserted-by":"crossref","unstructured":"Ala A, Stanca CM, Bu-Ghanim M et al (2006) Increased prevalence of primary biliary cirrhosis near superfund toxic waste sites.\u00a0Hepatology\u00a043:525\u2013531","DOI":"10.1002\/hep.21076"},{"key":"1517_CR4","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1136\/gut.2009.184218","volume":"59","author":"MI Prince","year":"2010","unstructured":"Prince MI, Ducker SJ, James OF (2010) Case-control studies of risk factors for primary biliary cirrhosis in two united kingdom populations. Gut 59:508\u2013512","journal-title":"Gut"},{"key":"1517_CR5","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1055\/s-0035-1567831","volume":"35","author":"AF Gulamhusein","year":"2015","unstructured":"Gulamhusein AF, Juran BD, Lazaridis KN (2015) Genome-wide association studies in primary biliary cirrhosis. Semin Liver Dis 35:392\u2013401","journal-title":"Semin Liver Dis"},{"key":"1517_CR6","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.jhep.2021.04.055","volume":"75","author":"HJ Cordell","year":"2021","unstructured":"Cordell HJ, Fryett JJ, Ueno K et al (2021) An international genome-wide meta-analysis of primary biliary cholangitis: novel risk loci and candidate drugs. J Hepatol 75:572\u2013581","journal-title":"J Hepatol"},{"key":"1517_CR7","doi-asserted-by":"crossref","first-page":"45","DOI":"10.2174\/156652409787314525","volume":"9","author":"C Selmi","year":"2009","unstructured":"Selmi C, Lleo A, Pasini S, Zuin M, Gershwin ME (2009) Innate immunity and primary biliary cirrhosis. Curr Mol Med 9:45\u201351","journal-title":"Curr Mol Med"},{"key":"1517_CR8","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1146\/annurev-pathol-020712-164014","volume":"8","author":"GM Hirschfield","year":"2013","unstructured":"Hirschfield GM, Gershwin ME (2013) The immunobiology and pathophysiology of primary biliary cirrhosis. Annu Rev Pathol 8:303\u2013330","journal-title":"Annu Rev Pathol"},{"key":"1517_CR9","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1136\/gut.2003.023937","volume":"53","author":"MI Prince","year":"2004","unstructured":"Prince MI, Chetwynd A, Craig WL, Metcalf JV, James OF (2004) Asymptomatic primary biliary cirrhosis: clinical features, prognosis, and symptom progression in a large population based cohort. Gut 53:865\u2013870","journal-title":"Gut"},{"key":"1517_CR10","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1002\/hep.29717","volume":"67","author":"CF Murillo Perez","year":"2018","unstructured":"Murillo Perez CF, Goet JC (2018) Milder disease stage in patients with primary biliary cholangitis over a 44-year period: a changing natural history. Hepatology 67:1920\u20131930","journal-title":"Hepatology"},{"key":"1517_CR11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12072-021-10276-6","volume":"16","author":"H You","year":"2022","unstructured":"You H, Ma X, Efe C et al (2022) APASL clinical practice guidance: the diagnosis and management of patients with primary biliary cholangitis. Hepatol Int 16:1\u201323","journal-title":"Hepatol Int"},{"key":"1517_CR12","doi-asserted-by":"crossref","unstructured":"Carbone M, Mells GF, Pells G et al (2013) Sex and age are determinants of the clinical phenotype of primary biliary cirrhosis and response to ursodeoxycholic acid. Gastroenterology 144:560\u2013569 e567; quiz e513\u2013564","DOI":"10.1053\/j.gastro.2012.12.005"},{"key":"1517_CR13","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1136\/gutjnl-2014-308351","volume":"65","author":"PJ Trivedi","year":"2016","unstructured":"Trivedi PJ, Lammers WJ, van Buuren HR et al (2016) Stratification of hepatocellular carcinoma risk in primary biliary cirrhosis: a multicentre international study. Gut 65:321\u2013329","journal-title":"Gut"},{"key":"1517_CR14","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1172\/JCI102222","volume":"28","author":"EH Ahrens Jr","year":"1949","unstructured":"Ahrens EH Jr, Kunkel HG (1949) The relationship between serum lipids and skin xanthomata in 18 patients with primary biliary cirrhosis. J Clin Investig 28:1565\u20131574","journal-title":"J Clin Investig"},{"key":"1517_CR15","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/S0016-5085(19)35377-6","volume":"37","author":"S Sherlock","year":"1959","unstructured":"Sherlock S (1959) Primary billiary cirrhosis (chronic intrahepatic obstructive jaundice). Gastroenterology 37:574\u2013586","journal-title":"Gastroenterology"},{"key":"1517_CR16","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/S0140-6736(65)91372-3","volume":"1","author":"JG Walker","year":"1965","unstructured":"Walker JG, Doniach D, Roitt IM, Sherlock S (1965) Serological tests in diagnosis of primary biliary cirrhosis. Lancet 1:827\u2013831","journal-title":"Lancet"},{"key":"1517_CR17","doi-asserted-by":"crossref","unstructured":"Beuers U, Gershwin ME, Gish RG et al (2015) Changing nomenclature for pbc: from 'cirrhosis' to 'cholangitis'.\u00a0Hepatology\u00a062:1620\u20131622","DOI":"10.1002\/hep.28140"},{"key":"1517_CR18","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1016\/S0140-6736(10)61965-4","volume":"377","author":"C Selmi","year":"2011","unstructured":"Selmi C, Bowlus CL, Gershwin ME, Coppel RL (2011) Primary biliary cirrhosis. Lancet 377:1600\u20131609","journal-title":"Lancet"},{"key":"1517_CR19","doi-asserted-by":"crossref","unstructured":"Lindor KD, Bowlus CL, Boyer J, Levy C, Mayo M (2019) Primary biliary cholangitis: 2018 practice guidance from the American Association for the Study of Liver Diseases.\u00a0Hepatology\u00a069:394\u2013419","DOI":"10.1002\/hep.30145"},{"key":"1517_CR20","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1136\/gutjnl-2017-315259","volume":"67","author":"GM Hirschfield","year":"2018","unstructured":"Hirschfield GM, Dyson JK, Alexander GJM et al (2018) The British Society of Gastroenterology\/UK-PBC primary biliary cholangitis treatment and management guidelines. Gut 67:1568\u20131594","journal-title":"Gut"},{"key":"1517_CR21","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/apt.13448","volume":"43","author":"KA Kim","year":"2016","unstructured":"Kim KA, Ki M, Choi HY, Kim BH, Jang ES, Jeong SH (2016) Population-based epidemiology of primary biliary cirrhosis in South Korea. Aliment Pharmacol Ther 43:154\u2013162","journal-title":"Aliment Pharmacol Ther"},{"key":"1517_CR22","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1111\/hepr.13342","volume":"49","author":"A Tanaka","year":"2019","unstructured":"Tanaka A, Mori M, Matsumoto K, Ohira H, Tazuma S, Takikawa H (2019) Increase trend in the prevalence and male-to-female ratio of primary biliary cholangitis, autoimmune hepatitis, and primary sclerosing cholangitis in Japan. Hepatol Res 49:881\u2013889","journal-title":"Hepatol Res"},{"key":"1517_CR23","volume":"8","author":"KS Cheung","year":"2017","unstructured":"Cheung KS, Seto WK, Fung J, Lai CL, Yuen MF (2017) Epidemiology and natural history of primary biliary cholangitis in the Chinese: a territory-based study in Hong Kong between 2000 and 2015. Clin Transl Gastroenterol 8:e116","journal-title":"Clin Transl Gastroenterol"},{"key":"1517_CR24","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1111\/jgh.14521","volume":"34","author":"S Chen","year":"2019","unstructured":"Chen S, Duan W, Li M et al (2019) Prognosis of 732 ursodeoxycholic acid-treated patients with primary biliary cholangitis: a single center follow-up study from China. J Gastroenterol Hepatol 34:1236\u20131241","journal-title":"J Gastroenterol Hepatol"},{"key":"1517_CR25","doi-asserted-by":"crossref","first-page":"7577","DOI":"10.1038\/s41598-019-44081-x","volume":"9","author":"CY Lin","year":"2019","unstructured":"Lin CY, Cheng YT, Chang ML, Chien RN (2019) The extrahepatic events of Asian patients with primary biliary cholangitis: a 30-year cohort study. Sci Rep 9:7577","journal-title":"Sci Rep"},{"key":"1517_CR26","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.cld.2018.03.001","volume":"22","author":"A Lleo","year":"2018","unstructured":"Lleo A, Colapietro F (2018) Changes in the epidemiology of primary biliary cholangitis. Clin Liver Dis 22:429\u2013441","journal-title":"Clin Liver Dis"},{"key":"1517_CR27","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1016\/j.jhep.2011.02.031","volume":"55","author":"C Corpechot","year":"2011","unstructured":"Corpechot C, Chazouill\u00e8res O, Poupon R (2011) Early primary biliary cirrhosis: Biochemical response to treatment and prediction of long-term outcome. J Hepatol 55:1361\u20131367","journal-title":"J Hepatol"},{"key":"1517_CR28","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.jhep.2019.04.001","volume":"71","author":"MH Harms","year":"2019","unstructured":"Harms MH, van Buuren HR, Corpechot C et al (2019) Ursodeoxycholic acid therapy and liver transplant-free survival in patients with primary biliary cholangitis. J Hepatol 71:357\u2013365","journal-title":"J Hepatol"},{"key":"1517_CR29","doi-asserted-by":"crossref","first-page":"170","DOI":"10.32074\/1591-951X-245","volume":"113","author":"S Sarcognato","year":"2021","unstructured":"Sarcognato S, Sacchi D, Grillo F et al (2021) Autoimmune biliary diseases: primary biliary cholangitis and primary sclerosing cholangitis. Pathologica 113:170\u2013184","journal-title":"Pathologica"},{"key":"1517_CR30","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1111\/apt.16023","volume":"52","author":"KK Leung","year":"2020","unstructured":"Leung KK, Deeb M, Hirschfield GM (2020) Review article: pathophysiology and management of primary biliary cholangitis. Aliment Pharmacol Ther 52:1150\u20131164","journal-title":"Aliment Pharmacol Ther"},{"key":"1517_CR31","doi-asserted-by":"crossref","unstructured":"Ludwig J, Dickson ER, McDonald GS (1978) Staging of chronic nonsuppurative destructive cholangitis (syndrome of primary biliary cirrhosis). Virchows Archiv. A, Pathol Anat Histol 379:103\u2013112","DOI":"10.1007\/BF00432479"},{"issue":"Suppl 4","key":"1517_CR32","first-page":"106","volume":"59","author":"PJ Scheuer","year":"1983","unstructured":"Scheuer PJ (1983) Primary biliary cirrhosis: diagnosis, pathology and pathogenesis. Postgrad Med J 59(Suppl 4):106\u2013115","journal-title":"Postgrad Med J"},{"key":"1517_CR33","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/j.1440-1827.2009.02500.x","volume":"60","author":"Y Nakanuma","year":"2010","unstructured":"Nakanuma Y, Zen Y, Harada K et al (2010) Application of a new histological staging and grading system for primary biliary cirrhosis to liver biopsy specimens: Interobserver agreement. Pathol Int 60:167\u2013174","journal-title":"Pathol Int"},{"key":"1517_CR34","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/j.humpath.2012.09.017","volume":"44","author":"Y Kakuda","year":"2013","unstructured":"Kakuda Y, Harada K, Sawada-Kitamura S et al (2013) Evaluation of a new histologic staging and grading system for primary biliary cirrhosis in comparison with classical systems. Hum Pathol 44:1107\u20131117","journal-title":"Hum Pathol"},{"key":"1517_CR35","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1111\/liv.12620","volume":"35","author":"D Wendum","year":"2015","unstructured":"Wendum D, Bo\u00eblle PY, Bedossa P et al (2015) Primary biliary cirrhosis: proposal for a new simple histological scoring system. Liver Int 35:652\u2013659","journal-title":"Liver Int"},{"key":"1517_CR36","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s00261-021-03335-x","volume":"48","author":"MA Morgan","year":"2023","unstructured":"Morgan MA, Sundaram KM (2023) Primary biliary cholangitis: review for radiologists. Abdom Radiol (NY) 48:127\u2013135","journal-title":"Abdom Radiol (NY)"},{"key":"1517_CR37","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1007\/s00330-011-2296-y","volume":"22","author":"JD Kova\u010d","year":"2012","unstructured":"Kova\u010d JD, Je\u0161i\u0107 R, Stanisavljevi\u0107 D et al (2012) Integrative role of MRI in the evaluation of primary biliary cirrhosis. Eur Radiol 22:688\u2013694","journal-title":"Eur Radiol"},{"key":"1517_CR38","doi-asserted-by":"crossref","first-page":"5139","DOI":"10.1007\/s00330-020-06855-0","volume":"30","author":"IS Idilman","year":"2020","unstructured":"Idilman IS, Venkatesh SH, Eaton JE et al (2020) Magnetic resonance imaging features in 283 patients with primary biliary cholangitis. Eur Radiol 30:5139\u20135148","journal-title":"Eur Radiol"},{"key":"1517_CR39","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.2214\/ajr.173.4.10511173","volume":"173","author":"GD Dodd 3rd","year":"1999","unstructured":"Dodd GD 3rd, Baron RL, Oliver JH 3rd, Federle MP (1999) Spectrum of imaging findings of the liver in end-stage cirrhosis: part i, gross morphology and diffuse abnormalities. AJR Am J Roentgenol 173:1031\u20131036","journal-title":"AJR Am J Roentgenol"},{"key":"1517_CR40","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1002\/(SICI)1522-2586(200002)11:2<136::AID-JMRI9>3.0.CO;2-B","volume":"11","author":"K Ito","year":"2000","unstructured":"Ito K, Mitchell DG, Gabata T (2000) Enlargement of hilar periportal space: a sign of early cirrhosis at MR imaging. J Magn Reson Imaging 11:136\u2013140","journal-title":"J Magn Reson Imaging"},{"key":"1517_CR41","doi-asserted-by":"crossref","unstructured":"Meng Y, Liang Y, Liu M (2015) The value of MRI in the diagnosis of primary biliary cirrhosis and assessment of liver fibrosis.\u00a0PLoS One\u00a010:e0120110","DOI":"10.1371\/journal.pone.0120110"},{"key":"1517_CR42","doi-asserted-by":"crossref","first-page":"885","DOI":"10.2214\/ajr.176.4.1760885","volume":"176","author":"JS Wenzel","year":"2001","unstructured":"Wenzel JS, Donohoe A, Ford KL 3rd, Glastad K, Watkins D, Molmenti E (2001) Primary biliary cirrhosis: MR imaging findings and description of MR imaging periportal halo sign. AJR Am J Roentgenol 176:885\u2013889","journal-title":"AJR Am J Roentgenol"},{"key":"1517_CR43","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.ejrad.2007.11.003","volume":"69","author":"N Haliloglu","year":"2009","unstructured":"Haliloglu N, Erden A, Erden I (2009) Primary biliary cirrhosis: Evaluation with t2-weighted MR imaging and MR cholangiopancreatography. Eur J Radiol 69:523\u2013527","journal-title":"Eur J Radiol"},{"key":"1517_CR44","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1148\/radiology.220.2.r01au36329","volume":"220","author":"A Blachar","year":"2001","unstructured":"Blachar A, Federle MP, Brancatelli G (2001) Primary biliary cirrhosis: clinical, pathologic, and helical ct findings in 53 patients. Radiology 220:329\u2013336","journal-title":"Radiology"},{"key":"1517_CR45","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s00261-004-0228-x","volume":"30","author":"S Kobayashi","year":"2005","unstructured":"Kobayashi S, Matsui O, Gabata T et al (2005) Mri findings of primary biliary cirrhosis: correlation with Scheuer histologic staging. Abdom Imaging 30:71\u201376","journal-title":"Abdom Imaging"},{"key":"1517_CR46","doi-asserted-by":"crossref","unstructured":"Guglielmo FF, Venkatesh SK, Mitchell DG (2019) Liver MR elastography technique and image interpretation: pearls and pitfalls. Radiographics 39:1983\u20132002","DOI":"10.1148\/rg.2019190034"},{"key":"1517_CR47","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1111\/j.1477-2574.2010.00223.x","volume":"12","author":"H Nilsson","year":"2010","unstructured":"Nilsson H, Blomqvist L, Douglas L, Nordell A, Jonas E (2010) Assessment of liver function in primary biliary cirrhosis using Gd-EOB-DTPA-enhanced liver MRI. HPB (Oxford) 12:567\u2013576","journal-title":"HPB (Oxford)"},{"key":"1517_CR48","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/s11604-019-00822-6","volume":"37","author":"D Han","year":"2019","unstructured":"Han D, Liu J, Jin E, He W (2019) Liver assessment using Gd-EOB-DTPA-enhanced magnetic resonance imaging in primary biliary cholangitis patients. Jpn J Radiol 37:412\u2013419","journal-title":"Jpn J Radiol"},{"key":"1517_CR49","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1148\/radiol.2021210531","volume":"302","author":"AA Perez","year":"2022","unstructured":"Perez AA, Noe-Kim V, Lubner MG et al (2022) Deep learning ct-based quantitative visualization tool for liver volume estimation: defining normal and hepatomegaly. Radiology 302:336\u2013342","journal-title":"Radiology"},{"key":"1517_CR50","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1056\/NEJMra043898","volume":"353","author":"MM Kaplan","year":"2005","unstructured":"Kaplan MM, Gershwin ME (2005) Primary biliary cirrhosis. N Engl J Med 353:1261\u20131273","journal-title":"N Engl J Med"},{"key":"1517_CR51","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s00261-016-1019-x","volume":"42","author":"N Malik","year":"2017","unstructured":"Malik N, Venkatesh SK (2017) Imaging of autoimmune hepatitis and overlap syndromes. Abdom Radiol (NY) 42:19\u201327","journal-title":"Abdom Radiol (NY)"},{"key":"1517_CR52","doi-asserted-by":"crossref","first-page":"E108","DOI":"10.1111\/hepr.12470","volume":"45","author":"Y Takeyama","year":"2015","unstructured":"Takeyama Y, Tsuchiya N, Kunimoto H et al (2015) Gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging as a useful detection method for advanced primary biliary cirrhosis. Hepatol Res 45:E108\u2013114","journal-title":"Hepatol Res"},{"key":"1517_CR53","doi-asserted-by":"crossref","unstructured":"Navasa M, Par\u00e9s A, Bruguera M, Caballer\u00eda J, Bosch J, Rod\u00e9s J (1987) Portal hypertension in primary biliary cirrhosis. Relationship with histological features. J Hepatol 5:292\u2013298","DOI":"10.1016\/S0168-8278(87)80035-1"},{"key":"1517_CR54","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1053\/j.gastro.2008.07.019","volume":"135","author":"PM Huet","year":"2008","unstructured":"Huet PM, Vincent C, Deslaurier J et al (2008) Portal hypertension and primary biliary cirrhosis: effect of long-term ursodeoxycholic acid treatment. Gastroenterology 135:1552\u20131560","journal-title":"Gastroenterology"},{"key":"1517_CR55","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s00535-021-01839-3","volume":"57","author":"L Burghart","year":"2022","unstructured":"Burghart L, Halilbasic E, Schwabl P et al (2022) Distinct prognostic value of different portal hypertension-associated features in patients with primary biliary cholangitis. J Gastroenterol 57:99\u2013110","journal-title":"J Gastroenterol"},{"key":"1517_CR56","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1007\/s10620-020-06498-7","volume":"66","author":"Y Natarajan","year":"2021","unstructured":"Natarajan Y, Tansel A, Patel P et al (2021) Incidence of hepatocellular carcinoma in primary biliary cholangitis: a systematic review and meta-analysis. Dig Dis Sci 66:2439\u20132451","journal-title":"Dig Dis Sci"},{"key":"1517_CR57","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1148\/radiol.2018181494","volume":"289","author":"V Chernyak","year":"2018","unstructured":"Chernyak V, Fowler KJ, Kamaya A, Kielar AZ, Elsayes KM, Bashir MR (2018) Liver imaging reporting and data system (li-rads) version 2018: imaging of hepatocellular carcinoma in at-risk patients. Radiology 289:816\u2013830","journal-title":"Radiology"},{"key":"1517_CR58","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.ultrasmedbio.2019.12.016","volume":"46","author":"I Gatos","year":"2020","unstructured":"Gatos I, Drazinos P, Yarmenitis S, Theotokas I, Zoumpoulis PS (2020) Comparison of sound touch elastography, shear wave elastography and vibration-controlled transient elastography in chronic liver disease assessment using liver biopsy as the \u201creference standard.\u201d Ultrasound Med Biol 46:959\u2013971","journal-title":"Ultrasound Med Biol"},{"key":"1517_CR59","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.21037\/qims-20-521","volume":"11","author":"L Yang","year":"2021","unstructured":"Yang L, Ling W, He D et al (2021) Shear wave-based sound touch elastography in liver fibrosis assessment for patients with autoimmune liver diseases. Quant Imaging Med Surg 11:1532\u20131542","journal-title":"Quant Imaging Med Surg"},{"key":"1517_CR60","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejrad.2022.110557","volume":"157","author":"I Gatos","year":"2022","unstructured":"Gatos I, Yarmenitis S, Theotokas I et al (2022) Comparison of visual transient elastography, vibration controlled transient elastography, shear wave elastography and sound touch elastography in chronic liver disease assessment using liver biopsy as \u201cgold standard.\u201d Eur J Radiol 157:110557","journal-title":"Eur J Radiol"},{"key":"1517_CR61","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1007\/s00261-014-0137-6","volume":"40","author":"Y Guo","year":"2015","unstructured":"Guo Y, Parthasarathy S, Goyal P, McCarthy RJ, Larson AC, Miller FH (2015) Magnetic resonance elastography and acoustic radiation force impulse for staging hepatic fibrosis: a meta-analysis. Abdom Imaging 40:818\u2013834","journal-title":"Abdom Imaging"},{"key":"1517_CR62","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1097\/MCG.0000000000001433","volume":"55","author":"KT Osman","year":"2021","unstructured":"Osman KT, Maselli DB, Idilman IS et al (2021) Liver stiffness measured by either magnetic resonance or transient elastography is associated with liver fibrosis and is an independent predictor of outcomes among patients with primary biliary cholangitis. J Clin Gastroenterol 55:449\u2013457","journal-title":"J Clin Gastroenterol"},{"key":"1517_CR63","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1136\/gutjnl-2017-315384","volume":"67","author":"M Renzulli","year":"2018","unstructured":"Renzulli M, Biselli M, Brocchi S et al (2018) New hallmark of hepatocellular carcinoma, early hepatocellular carcinoma and high-grade dysplastic nodules on Gd-EOB-DTPA MRI in patients with cirrhosis: a new diagnostic algorithm. Gut 67:1674\u20131682","journal-title":"Gut"},{"key":"1517_CR64","doi-asserted-by":"crossref","first-page":"5840","DOI":"10.1007\/s00330-021-07702-6","volume":"31","author":"C Liu","year":"2021","unstructured":"Liu C, Sun Y, Yang Y et al (2021) Gadobenate dimeglumine-enhanced biliary imaging from the hepatobiliary phase can predict progression in patients with liver cirrhosis. Eur Radiol 31:5840\u20135850","journal-title":"Eur Radiol"},{"key":"1517_CR65","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1007\/s00261-020-02578-4","volume":"45","author":"F Vernuccio","year":"2020","unstructured":"Vernuccio F, Cannella R, Gozzo C et al (2020) Hepatic enhancement in cirrhosis in the portal venous phase: what are the differences between gadoxetate disodium and gadobenate dimeglumine? Abdom Radiol (NY) 45:2409\u20132417","journal-title":"Abdom Radiol (NY)"},{"key":"1517_CR66","doi-asserted-by":"crossref","first-page":"3090","DOI":"10.1007\/s00330-018-5884-2","volume":"29","author":"C KhouriChalouhi","year":"2019","unstructured":"KhouriChalouhi C, Vernuccio F, Rini F et al (2019) Hepatobiliary phase in cirrhotic patients with different model for end-stage liver disease score: Comparison of the performance of gadoxetic acid to gadobenate dimeglumine. Eur Radiol 29:3090\u20133099","journal-title":"Eur Radiol"},{"key":"1517_CR67","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1148\/radiol.2019190734","volume":"294","author":"N Bastati","year":"2020","unstructured":"Bastati N, Beer L, Mandorfer M et al (2020) Does the functional liver imaging score derived from gadoxetic acid-enhanced MRI predict outcomes in chronic liver disease? Radiology 294:98\u2013107","journal-title":"Radiology"},{"key":"1517_CR68","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s00005-019-00550-9","volume":"67","author":"GN Dalekos","year":"2019","unstructured":"Dalekos GN, Gatselis NK (2019) Variant and specific forms of autoimmune cholestatic liver diseases. Arch Immunol Ther Exp 67:197\u2013211","journal-title":"Arch Immunol Ther Exp"},{"key":"1517_CR69","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.jhep.2010.09.002","volume":"54","author":"KM Boberg","year":"2011","unstructured":"Boberg KM, Chapman RW, Hirschfield GM, Lohse AW, Manns MP, Schrumpf E (2011) Overlap syndromes: The International Autoimmune Hepatitis Group (IAIHG) position statement on a controversial issue. J Hepatol 54:374\u2013385","journal-title":"J Hepatol"},{"key":"1517_CR70","first-page":"1","volume":"32","author":"GN Dalekos","year":"2019","unstructured":"Dalekos GN, Koskinas J, Papatheodoridis GV (2019) Hellenic association for the study of the liver clinical practice guidelines: autoimmune hepatitis. Ann Gastroenterol 32:1\u201323","journal-title":"Ann Gastroenterol"},{"key":"1517_CR71","doi-asserted-by":"crossref","first-page":"23","DOI":"10.5604\/01.3001.0012.7858","volume":"18","author":"RS Goertz","year":"2019","unstructured":"Goertz RS, GaBmann L, Strobel D et al (2019) Acoustic radiation force impulse (ARFI) elastography in autoimmune and cholestatic liver diseases. Ann Hepatol 18:23\u201329","journal-title":"Ann Hepatol"},{"key":"1517_CR72","first-page":"1019","volume":"30","author":"LL Sun","year":"2016","unstructured":"Sun LL, Dong G, Wang B, Zheng Q, Wang S, Zhang RF (2016) Real-time shear wave elastrography and apri index for evaluating autoimmune hepatitis fibrosis. J Biol Regul Homeost Agents 30:1019\u20131021","journal-title":"J Biol Regul Homeost Agents"},{"key":"1517_CR73","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1016\/S0140-6736(18)30300-3","volume":"391","author":"JK Dyson","year":"2018","unstructured":"Dyson JK, Beuers U, Jones DEJ, Lohse AW, Hudson M (2018) Primary sclerosing cholangitis. Lancet 391:2547\u20132559","journal-title":"Lancet"},{"key":"1517_CR74","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1053\/j.gastro.2009.11.046","volume":"138","author":"TH Karlsen","year":"2010","unstructured":"Karlsen TH, Franke A, Melum E et al (2010) Genome-wide association analysis in primary sclerosing cholangitis. Gastroenterology 138:1102\u20131111","journal-title":"Gastroenterology"},{"key":"1517_CR75","doi-asserted-by":"crossref","unstructured":"Khoshpouri P, Habibabadi RR, Hazhirkarzar B, Ameli S, Ghadimi M, Ghasabeh MA (2019) Imaging features of primary sclerosing cholangitis: from diagnosis to liver transplant follow-up. Radiographics 39:1938\u20131964","DOI":"10.1148\/rg.2019180213"},{"key":"1517_CR76","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1007\/s00330-021-08147-7","volume":"32","author":"SK Venkatesh","year":"2022","unstructured":"Venkatesh SK, Welle CL, Miller FH et al (2022) Reporting standards for primary sclerosing cholangitis using MRI and MR cholangiopancreatography: guidelines from MR Working Group of the International Primary Sclerosing Cholangitis Study Group. Eur Radiol 32:923\u2013937","journal-title":"Eur Radiol"},{"key":"1517_CR77","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1148\/rg.357150066","volume":"35","author":"A Mart\u00ednez-de-Alegr\u00eda","year":"2015","unstructured":"Mart\u00ednez-de-Alegr\u00eda A, Baleato-Gonz\u00e1lez S, Garc\u00eda-Figueiras R et al (2015) Igg4-related disease from head to toe. Radiographics 35:2007\u20132025","journal-title":"Radiographics"},{"key":"1517_CR78","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.rcl.2015.12.009","volume":"54","author":"C Guidry","year":"2016","unstructured":"Guidry C, Fricke RG, Ram R, Pandey T, Jambhekar K (2016) Imaging of sarcoidosis: a contemporary review. Radiol Clin North Am 54:519\u2013534","journal-title":"Radiol Clin North Am"},{"key":"1517_CR79","doi-asserted-by":"crossref","unstructured":"Lampert F (1998) Langerhans cell histiocytosis. Historical perspectives. Hematol\/Oncol Clin North Am 12:213\u2013219","DOI":"10.1016\/S0889-8588(05)70506-2"},{"key":"1517_CR80","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1186\/s40792-020-00899-6","volume":"6","author":"M Murakami","year":"2020","unstructured":"Murakami M, Onishi S, Ohya Y et al (2020) Langerhans cell histiocytosis confined to extrahepatic bile duct causing sclerosing cholangitis in child: a case report. Surg Case Rep 6:137","journal-title":"Surg Case Rep"},{"key":"1517_CR81","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1159\/000521972","volume":"38","author":"S Aldarwish","year":"2022","unstructured":"Aldarwish S, Schafmayer C, Erbersdobler A, Hinz S (2022) An extremely rare cause of an obstructive jaundice in adults: limited Langerhans cell histiocytosis of the extrahepatic bile duct. Visc Med 38:295\u2013299","journal-title":"Visc Med"},{"key":"1517_CR82","doi-asserted-by":"crossref","DOI":"10.12659\/AJCR.937628","volume":"23","author":"M Consing","year":"2022","unstructured":"Consing M, Lee HE, Jess H, Vahidi S (2022) Solitary involvement of the liver: a rare manifestation of Langerhans cell histiocytosis. Am J Case Rep 23:e937628","journal-title":"Am J Case Rep"},{"key":"1517_CR83","doi-asserted-by":"crossref","first-page":"W551","DOI":"10.2214\/AJR.10.4341","volume":"197","author":"OJ O'Connor","year":"2011","unstructured":"O\u2019Connor OJ, O\u2019Neill S, Maher MM (2011) Imaging of biliary tract disease. AJR Am J Roentgenol 197:W551\u2013558","journal-title":"AJR Am J Roentgenol"},{"key":"1517_CR84","doi-asserted-by":"crossref","unstructured":"Corpechot C, Abenavoli L, Rabahi N et al (2008) Biochemical response to ursodeoxycholic acid and long-term prognosis in primary biliary cirrhosis.\u00a0Hepatology\u00a048:871\u2013877","DOI":"10.1002\/hep.22428"}],"container-title":["Insights into Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13244-023-01517-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13244-023-01517-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13244-023-01517-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,18]],"date-time":"2023-11-18T01:04:57Z","timestamp":1700269497000},"score":1,"resource":{"primary":{"URL":"https:\/\/insightsimaging.springeropen.com\/articles\/10.1186\/s13244-023-01517-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,26]]},"references-count":84,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1517"],"URL":"https:\/\/doi.org\/10.1186\/s13244-023-01517-3","relation":{},"ISSN":["1869-4101"],"issn-type":[{"value":"1869-4101","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,26]]},"assertion":[{"value":"26 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 October 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Bin Song is a Deputy Editor of <i>Insights into Imaging<\/i>. He has not taken part in the review or selection process of this article.All remaining authors disclose no conflict of interest relevant to this work.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"180"}}